Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Capital Employed (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Return on Capital Employed for 15 consecutive years, with 0.07% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 9.0% to 0.07% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.07%, a 9.0% decrease, with the full-year FY2024 number at 0.12%, down 7.0% from a year prior.
  • Return on Capital Employed was 0.07% for Q3 2025 at Usana Health Sciences, down from 0.09% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.72% in Q1 2022 to a low of 0.07% in Q3 2025.
  • A 5-year average of 0.28% and a median of 0.16% in 2024 define the central range for Return on Capital Employed.
  • Biggest YoY gain for Return on Capital Employed was 33bps in 2022; the steepest drop was -60bps in 2022.
  • Usana Health Sciences' Return on Capital Employed stood at 0.7% in 2021, then crashed by -82bps to 0.12% in 2022, then skyrocketed by 50bps to 0.19% in 2023, then plummeted by -38bps to 0.12% in 2024, then crashed by -41bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for USNA's Return on Capital Employed are 0.07% (Q3 2025), 0.09% (Q2 2025), and 0.09% (Q1 2025).